Data gathered: January 10
Alternative Data for Praxis Precision Medicines Inc
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 23,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 958 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
| Price | $63.15 |
| Target Price | Sign up |
| Volume | 292,620 |
| Market Cap | $1.37B |
| Year Range | $36.55 - $84.83 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of “Moderate Buy” from AnalystsJanuary 3 - ETF Daily News |
|
Geode Capital Management LLC Has $22.95 Million Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)December 28 - ETF Daily News |
|
State Street Corp Sells 29,518 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)December 20 - ETF Daily News |
|
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $913,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)December 19 - ETF Daily News |
|
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock Position Increased by Wellington Management Group LLPDecember 15 - ETF Daily News |
 |
HC Wainwright Reaffirms Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)December 14 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 300,000 | 15M | -15M | -52M | -57M | -2.750 |
| Q2 '24 | 360,000 | 11M | -10M | -33M | -37M | -1.740 |
| Q1 '24 | 430,000 | 15M | -15M | -40M | -42M | -2.840 |
| Q4 '23 | 520,000 | 9.9M | -9.4M | -27M | -28M | -2.970 |
| Q3 '23 | 470,000 | 8.7M | -8.3M | -25M | -26M | -0.180 |
Insider Transactions View All
| Mastrocola Lauren filed to sell 5,613 shares at $81.8. November 15 '24 |
| Nemiroff Alex filed to sell 10,301 shares at $80.2. November 15 '24 |
| DeSimone Jill filed to buy 14,500 shares at $1.8. October 10 '23 |
| Souza Marcio filed to buy 45,002 shares at $1.1. June 27 '23 |
| Kelly Timothy Edwin filed to buy 46,416 shares at $0.9. March 27 '23 |
Similar companies
Read more about Praxis Precision Medicines Inc (PRAX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Praxis Precision Medicines Inc?
The Market Cap of Praxis Precision Medicines Inc is $1.37B.
What is the current stock price of Praxis Precision Medicines Inc?
Currently, the price of one share of Praxis Precision Medicines Inc stock is $63.15.
How can I analyze the PRAX stock price chart for investment decisions?
The PRAX stock price chart above provides a comprehensive visual representation of Praxis Precision Medicines Inc's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Praxis Precision Medicines Inc shares. Our platform offers an up-to-date PRAX stock price chart, along with technical data analysis and alternative data insights.
Does PRAX offer dividends to its shareholders?
As of our latest update, Praxis Precision Medicines Inc (PRAX) does not offer dividends to its shareholders. Investors interested in Praxis Precision Medicines Inc should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Praxis Precision Medicines Inc?
Some of the similar stocks of Praxis Precision Medicines Inc are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.